Journal article
Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study
Middle-income countries (MICs) that are not eligible for funding from Gavi, the Vaccine Alliance, have been slow to adopt rotavirus vaccines. Few studies have evaluated the cost-effectiveness and benefit–risk of rotavirus vaccination in these settings. We aimed to assess the potential economic and health impact of rotavirus vaccination in 63 MICs not eligible for funding from Gavi.
Authors
Languages
- English
Publication year
2021
Journal
The Lancet
Volume
9
Type
Journal article
Categories
- Programme management
Diseases
- Rotavirus
Tags
- Planning, budgeting and financing